Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

LGR5 mainly stays inside cells, moving to the trans-Golgi network, and this process is important for its role in cell signaling.

Fibrosing alopecia can be diagnosed without typical signs of lichen planopilaris.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Frontal fibrosing alopecia significantly affects men, often causing hair loss in eyebrows, beard, and sideburns.

Brownish halos around axillary hair can help diagnose frontal fibrosing alopecia.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

The new tool helps measure the impact of alopecia areata on children's quality of life.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Inflammatory diets may increase the risk and severity of alopecia areata.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

RALF22 is essential for root hair growth in response to fungal emissions in Arabidopsis.

Frontal fibrosing alopecia has occurred in two related male families.

Amla fruit syrup improved hair growth and satisfaction in women with hair loss without significant side effects.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

ALUDWIG can help standardize female hair loss assessment from a single image.

Infliximab may cause hair loss in Crohn's disease patients.

Early diagnosis and quick treatment improve life quality for FFA patients.

Alopecia areata affects 1.2% to 2.3% of Australians, with many unaware of treatment options.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.